Here are the minutes for the TM telcon:
http://www.w3.org/2011/06/16-hcls2-minutes.html
Thanks to Bob for scribing!
-Scott
--
M. Scott Marshall, W3C HCLS IG co-chair, http://www.w3.org/blog/hcls
http://staff.science.uva.nl/~marshall
Here are the minutes from the LODD telcon on Wed:
http://www.w3.org/2011/06/15-hcls-minutes.html
After the minutes were already generated:
17:00 AnjaI wonder if it makes sense to have provenance data on the
linksets provided via D2R as a plugin as well
17:00 Anjathis would cover the co
Eric wrote:
Join me tomorrow at the usual time (11.00 EDT, 15.00Z)?
I somehow missed that sentence and was not aware of the HCLS telecon
today -- sorry I didn't attend!
- Matthias
:-) Then I withdraw my objection :-)
M
On Thu, 16 Jun 2011 09:49:55 -0700, Helena Deus
wrote:
Ups, now I noticed my mistake and your objection :-)
What I meant to say is :
myinstance:drugX rdf:type myshema:drug .
myinstance:drugX owl:sameAs someoneElsesInstance:drugX .
-Original M
On Thu, 16 Jun 2011 09:06:47 -0700, Helena Deus
wrote:
Great to hear from you.
Always nice to hear from you too!!
M
On Thu, 16 Jun 2011 09:06:47 -0700, Helena Deus
wrote:
I thought the drugs we two individuals (instances of drugs).
< :drugX rdf:type myshema:drug >
Here you are saying X is "type drug", asserting that "myschema:drug" is an
OWL Class. Therefore...
< myschema:drug owl:sameAs
Ups, now I noticed my mistake and your objection :-)
What I meant to say is :
myinstance:drugX rdf:type myshema:drug .
myinstance:drugX owl:sameAs someoneElsesInstance:drugX .
-Original Message-
From: Mark Wilkinson [mailto:ma...@illuminae.com]
Sent: 16 June 2011 16:18
To: linkedlifedat
Hi Mark,
Great to hear from you. What would you recommend instead?
I thought the drugs we two individuals (instances of drugs).
On Thu, Jun 16, 2011 at 4:18 PM, Mark Wilkinson wrote:
>
> < :drugX rdf:type myshema:drug > and then somewhere else state that
>> < myschema:drug owl:sameAs someother
Thanks lena, very helpful
claus
- Original meddelelse -
> Hi Claus, all
>
> Lately I have been preferring the second option, for
> provenance/attribution issues - I want to be able to separate my list
> of instances of a class from the list of instances defined somewhere
> else. A neat
Some suggestions for the Use Cases document:
1. Change the title of the "Pharma Co-vigilence" section to the
"Healthcare Quality Measurement and Pharmacovigilence"
2. Add a section:
[[
Personalized Medicine
The ability to connect previously disparate healthcare research and
outcomes information
Thanks to Bob Powers for scribing again! Draft minutes are at:
http://www.w3.org/2011/06/16-hcls-minutes.html
and below in plain text.
---
[1]W3C
[1] http://www.w3.org/
- DRAFT -
if "*Structured protocols* and experimental results" is added to the High
Level Use cases then in the Life Sciences domain there should also be:
Biomedical experimental data repositories: although experimental
protocols, methods and datasets are related, they are not always openly
accessible and
Quick reminder of today's teleconference call:
''' Conference Details'''
* Date of Call: Thursday June 16 2011
* Time of Call: 12:00pm - 1:00pm ET
* Dial-In #: +1.617.761.6200 (Cambridge, MA)
* Dial-In #: +33.4.26.46.79.03 (Paris, France)
* Dial-In #: +44.203.318.0479 (London, UK)
* Particip
< "drugX" rdf:type myshema:drug > and then somewhere else state that
< myschema:drug owl:sameAs someother:drug >.
I wouldn't advise this - it's an OWL Full construct. You can only use
sameAs to merge two *individuals* in OWL DL.
Mark
--
Dr. Mark Wilkinson
Assistant Professor, Medica
hi all,
regrets also and +1 to both of lena's points
cheers,
michael
*From:* public-semweb-lifesci-requ...@w3.org [mailto:
public-semweb-lifesci-requ...@w3.org] *On Behalf Of *Helena Deus
*Sent:* Thursday, June 16, 2011 7:56 AM
*To:* Eric Prud'hommeaux
*Cc:* public-semweb-lifesci@w3.org
*
Regrets, I cannot attend the call :-(
A few points:
1. Suggest to change in the High Level Use cases
- *Structured protocols* and experimental results
I think we need to elaborate at least one of the use cases and describe them
as a workflow (e.g. user needs to find about a pathway where two pro
Hi Claus, all
Lately I have been preferring the second option, for provenance/attribution
issues - I want to be able to separate my list of instances of a class from
the list of instances defined somewhere else. A neat way to do that is to
say that
< "drugX" rdf:type myshema:drug > and then somew
Hi all;
Some folks on my group (oeg-upm.net) have developed software for
migrating different resources to RDF and other software for producing
Linked Data. Perhaps it would be interesting to have one of them (Boris
Villazon Terrazas) on a telco to explain the software, specially w.r.t
the W3C
Hi Egon, others,
Sorry I wasn't able to make it. I'm at the ACM Webscience meeting in Koblenz,
Germany.
Joanne
On Jun 15, 2011, at 6:36 PM, Paul Rigor wrote:
> Hi all,
>
> I was wondering whether the minutes are available for today's teleconference?
>
> Thanks,
> Paul
>
> On Wed, Jun 15,
19 matches
Mail list logo
